LAMICTAL XR 250 (Lamictal XR 250 mg)
Generic Name: lamotrigine
Pill imprint LAMICTAL XR 250 has been identified as Lamictal XR 250 mg.
Lamictal XR is used in the treatment of seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamictal XR 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- lamotrigine
- Imprint:
- LAMICTAL XR 250
- Strength:
- 250 mg
- Color:
- Purple / White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0781
- Inactive Ingredients:
- glyceryl monostearate
hypromelloses
lactose monohydrate
magnesium stearate
methacrylic acid
polyethylene glycol 400
polysorbate 80
titanium dioxide
triethyl citrate
cochineal
ferrosoferric oxide
FD&C Blue No. 2
More about Lamictal XR (lamotrigine)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
